[{"AccountsPayableCurrent_0_Q2_USD":12582000.0,"IncreaseDecreaseInContractWithCustomerAsset_2_Q2_USD":0.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":323263000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":21431000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":155446000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":479746000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-119000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-771000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":105000000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":7396000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":944000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":37333000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-119000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-771000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-140167000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-68012000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":0.0,"ProvisionForDoubtfulAccounts_1_Q2_USD":0.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1247158000.0,"RepaymentsOfRelatedPartyDebt_2_Q2_USD":0.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":823000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":188385000.0,"NonoperatingIncomeExpense_2_Q2_USD":4146000.0,"NonoperatingIncomeExpense_1_Q2_USD":1691000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":8000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":8000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":10609000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":17603000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":7849000.0,"MarketableSecurities_0_Q2_USD":454890000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":7152000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":7090000.0,"RestrictedInvestmentsNoncurrent_0_Q2_USD":2125000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":818182000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":652000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":20096000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":15282000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1424000.0,"NoncashOrPartNoncashAcquisitionInventoryAcquired1_2_Q2_USD":591000.0,"MarketableSecuritiesUnrealizedGainLoss_2_Q2_USD":-119000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q2_USD":-771000.0,"InventoryWriteDown_1_Q2_USD":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":525000.0,"InventoryWriteDown_2_Q2_USD":0.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":765000.0,"IncreaseDecreaseOfRestrictedInvestments_2_Q2_USD":615000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-2436000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":35126000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":476321000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_2_Q2_USD":83000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedGain_2_Q2_USD":75000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":476329000.0,"AssetsFairValueDisclosure_0_Q2_USD":617697000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":10609000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":17603000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":2010000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":624000.0,"SignificantSupplyCommitmentRemainingMinimumAmountCommitted_0_Q2_USD":5000000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":4146000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":2381000.0,"NetIncomeLoss_1_Q2_USD":-67241000.0,"NetIncomeLoss_2_Q2_USD":-140048000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-141214000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-19441000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":195781000.0,"LiabilitiesCurrent_0_Q2_USD":51339000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":686305000.0,"Liabilities_0_Q2_USD":66621000.0,"InventoryNet_0_Q2_USD":1389000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":146000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":7384000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-7056000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-2.56,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.2,"CostsAndExpenses_2_Q2_USD":151346000.0,"CostsAndExpenses_1_Q2_USD":76022000.0,"CommonStockValue_0_Q2_USD":561000.0,"CommonStockSharesOutstanding_0_Q2_shares":56081993.0,"CommonStockSharesIssued_0_Q2_shares":56081993.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":155446000.0,"AssetsCurrent_0_Q2_USD":633086000.0,"Assets_0_Q2_USD":686305000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7580330.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-8000.0,"AccountsReceivableNetCurrent_0_Q2_USD":7384000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":3653000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":13977000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":189037000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":9567000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":0.0,"IncreaseDecreaseInInventories_2_Q2_USD":798000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":7396000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":4827000.0,"ShareBasedCompensation_2_Q2_USD":17603000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":53869000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":29933000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":97469000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":46081000.0,"PreferredStockValue_0_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":1691000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"OperatingIncomeLoss_2_Q2_USD":-144194000.0,"OperatingIncomeLoss_1_Q2_USD":-68932000.0,"InterestPaidNet_2_Q2_USD":0.0,"InterestExpense_2_Q2_USD":0.0,"InterestExpense_1_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":125000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommitmentsAndContingencies_0_Q2_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":54743778.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":55920122.0,"StockholdersEquity_0_Q2_USD":619684000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-628027000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"ValuationAllowancesAndReservesBalance_0_Q2_USD":509000.0,"Ticker":"DCPH","CIK":"1654151","name":"DECIPHERA PHARMACEUTICALS, INC.","OfficialName":"Deciphera Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"586694767.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200804"}]